£69.91

Humana Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Price data last checked 21 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£70 today · usual range £33–£70 · best ever £33

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days · 70 data points (no recent data)

Historical
Generating forecast…
£70.20 £29.13 £38.09 £47.05 £56.01 £64.97 £73.93 25 April 2026 12 May 2026 29 May 2026 15 June 2026 03 July 2026

Price Distribution

Price distribution over 70 days • 2 price levels

Days at Price
Current Price
4 days 66 days · current 0 17 33 50 66 £33 £70 Days at Price

Price Analysis

Most common price: £70 (66 days, 94.3%)

Price range: £33 - £70

Price levels: 2 different prices over 70 days

Description

This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer’s disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Comprehensive and cutting-edge, Biomarkers for Preclinical Alzheimer’s Disease is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry.”

Product Specifications

Brand
Humana
Format
hardcover
Domain
Amazon UK
Release Date
27 February 2018
Listed Since
02 November 2017

Barcode

No barcode data available

Similar Products You Might Like

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
98% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.54 13 Jul 2026
Biomarkers for Early Diagnosis of Alzheimer's Disease
98% match

Biomarkers for Early Diagnosis of Alzheimer's Disease

£66.04 10 Jul 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
97% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.81 09 Jul 2026
Early Detection of Alzheimer’s Disease: Biological and Technological Advances
97% match

Early Detection of Alzheimer’s Disease: Biological and Technological Advances

Academic Press

£102.79 10 Jul 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
97% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Jul 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
97% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 03 Jul 2026
The End of Alzheimer's: The Brain and Beyond
97% match

The End of Alzheimer's: The Brain and Beyond

Academic Press

£50.59 07 Jul 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
97% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£11.43 04 Jul 2026
Neuroprotection in Alzheimer's Disease
97% match

Neuroprotection in Alzheimer's Disease

Academic Press

£88.59 10 Jul 2026
Smart Diagnostics for Neurodegenerative Disorders: Neuro-sensors
97% match

Smart Diagnostics for Neurodegenerative Disorders: Neuro-sensors

Academic Press

£100.89 10 Jul 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume IV: Molecular Genetic and Genomic Markers: 04
96% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume IV: Molecular Genetic and Genomic Markers: 04

Springer

£105.90 24 Jun 2026
Alzheimer’s Disease Estimation: A Pattern Recognition based Approach using MRI and Genotype Data
96% match

Alzheimer’s Disease Estimation: A Pattern Recognition based Approach using MRI and Genotype Data

LAP Lambert Academic Publishing

£63.00 04 Jul 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume III: Metabolic and Peripheral Biomarkers: 03
96% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume III: Metabolic and Peripheral Biomarkers: 03

Springer

£107.85 08 Jul 2026
Systems Biology of Alzheimer's Disease: 1303 (Methods in Molecular Biology, 1303)
96% match

Systems Biology of Alzheimer's Disease: 1303 (Methods in Molecular Biology, 1303)

Humana

£91.80 15 Jul 2026
Case Studies in Dementia: Volume 2: Common and Uncommon Presentations (Case Studies in Neurology)
96% match

Case Studies in Dementia: Volume 2: Common and Uncommon Presentations (Case Studies in Neurology)

Cambridge University Press

£42.72 13 Jul 2026
ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)
96% match

ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)

Imperial College Press

£80.01 30 Jun 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
96% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£179.95 27 Jun 2026